A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats.

por Marinelli, A., van de Velde, C. J., Kuppen, P. J., Franken, H. C., Souverijn, J. H., Eggermont, A. M.
Publicado 1990

Variations in exposure to mitomycin C in an in vitro colony-forming assay.

por Slee, P. H., de Bruijn, E. A., Leeflang, P., Kuppen, P. J., van den Berg, L., van Oosterom, A. T.
Publicado 1986

Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.

por Marinelli, A., Dijkstra, F. R., van Dierendonck, J. H., Kuppen, P. J., Cornelisse, C. J., van de Velde, C. J.
Publicado 1991

Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer

por Benard, A, van de Velde, C J H, Lessard, L, Putter, H, Takeshima, L, Kuppen, P J K, Hoon, D S B
Publicado 2013

Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.

por Marinelli, A., van Dierendonck, J. H., van Brakel, G. M., Irth, H., Kuppen, P. J., Tjaden, U. R., van de Velde, C. J.
Publicado 1991

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.

por Kuppen, P. J., Jonges, L. E., van de Velde, C. J., Vahrmeijer, A. L., Tollenaar, R. A., Borel Rinkes, I. H., Eggermont, A. M.
Publicado 1997

Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer

por Baart, V. M., Houvast, R. D., de Geus-Oei, L. F., Quax, P. H. A., Kuppen, P. J. K., Vahrmeijer, A. L., Sier, C. F. M.
Publicado 2020

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients

por Zeestraten, E C M, Reimers, M S, Saadatmand, S, Dekker, J-W T, Liefers, G J, van den Elsen, P J, van de Velde, C J H, Kuppen, P J K
Publicado 2014

Assessment of DNA methylation status in early stages of breast cancer development

por van Hoesel, A Q, Sato, Y, Elashoff, D A, Turner, R R, Giuliano, A E, Shamonki, J M, Kuppen, P J K, van de Velde, C J H, Hoon, D S B
Publicado 2013

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients

por Zeestraten, E C M, Reimers, M S, Saadatmand, S, Goossens-Beumer, I J, Dekker, J-W T, Liefers, G J, van den Elsen, P J, van de Velde, C J H, Kuppen, P J K
Publicado 2014

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma

por Vangangelt, K. M. H., van Pelt, G. W., Engels, C. C., Putter, H., Liefers, G. J., Smit, V. T. H. B. M., Tollenaar, R. A. E. M., Kuppen, P. J. K., Mesker, W. E.
Publicado 2017

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

por Zeestraten, E C M, Maak, M, Shibayama, M, Schuster, T, Nitsche, U, Matsushima, T, Nakayama, S, Gohda, K, Friess, H, van de Velde, C J H, Ishihara, H, Rosenberg, R, Kuppen, P J K, Janssen, K-P
Publicado 2012

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

por Zeestraten, E C M, Maak, M, Shibayama, M, Schuster, T, Nitsche, U, Matsushima, T, Nakayama, S, Gohda, K, Friess, H, van de Velde, C J H, Ishihara, H, Rosenberg, R, Kuppen, P J K, Janssen, K-P
Publicado 2012

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

por Engels, C C, Fontein, D B Y, Kuppen, P J K, de Kruijf, E M, Smit, V T H B M, Nortier, J W R, Liefers, G J, van de Velde, C J H, Bastiaannet, E
Publicado 2014

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients

por van Nes, J G H, Smit, V T H B M, Putter, H, Kuppen, P J, Kim, S J, Daito, M, Ding, J, Shibayama, M, Numada, S, Gohda, K, Matsushima, T, Ishihara, H, Noguchi, S, van de Velde, C J H
Publicado 2009

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer

por Goossens-Beumer, I J, Zeestraten, E C M, Benard, A, Christen, T, Reimers, M S, Keijzer, R, Sier, C F M, Liefers, G J, Morreau, H, Putter, H, Vahrmeijer, A L, van de Velde, C J H, Kuppen, P J K
Publicado 2014

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with color...

por Vahrmeijer, A L, van Dierendonck, J H, Keizer, H J, Beijnen, J H, Tollenaar, R A E M, Pijl, M E J, Marinelli, A, Kuppen, P J K, van Bockel, J H, Mulder, G J, Velde, C J H van de
Publicado 2000

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy:...

por Engels, C. C., Charehbili, A., van de Velde, C. J. H., Bastiaannet, E., Sajet, A., Putter, H., van Vliet, E. A., van Vlierberghe, R. L. P., Smit, V. T. H. B. M., Bartlett, J. M. S., Seynaeve, C., Liefers, G. J., Kuppen, P. J. K.
Publicado 2015

Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment

por Vuijk, F. A., de Muynck, L. D. A. N., Franken, L. C., Busch, O. R., Wilmink, J. W., Besselink, M. G., Bonsing, B. A., Bhairosingh, S. S., Kuppen, P. J. K., Mieog, J. S. D., Sier, C. F. M., Vahrmeijer, A. L., Verheij, J., Fariňa-Sarasqueta, A., Swijnenburg, R. J.
Publicado 2020

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemoth...

por de Groot, A. F., Blok, E. J., Charehbili, A., Engels, C. C., Smit, V. T. H. B. M., Dekker-Ensink, N. G., Putter, H., Meershoek-Klein Kranenbarg, E., van de Velde, C. J. H., Liefers, G. J., Nortier, J. W. R., Kuppen, P. J. K., van der Burg, S. H., Kroep, J. R.
Publicado 2019